Hydrogen Therapy Protects Against Tissue Damage from Blood Flow Loss
- Authors
- Branislav Kura, Jan Slezak
- Journal
- International Journal of Molecular Sciences
- Year
- 2024
- DOI
- 10.3390/ijms25147884
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Slovakia
- Health Condition
- Ischemia/Reperfusion Injury
- Body System
- Cardiovascular
TL;DR
Scientists found that a special type of hydrogen gas can protect your body's organs from damage that happens when blood flow gets cut off and then suddenly restored again—like what happens during a heart attack or stroke. This could be a simple, safe new treatment to help people recover better from these serious medical emergencies.
Key Finding
Molecular hydrogen showed protective effects against ischemia/reperfusion injury in laboratory and animal models across multiple organs by reducing oxidative stress, inflammation, and cellular damage.
Summary
This review examined how molecular hydrogen—a simple gas—might protect organs from damage that occurs when blood flow is cut off and then restored (a condition called ischemia/reperfusion injury). This type of injury happens during heart attacks, strokes, and organ transplants. The review found that in laboratory and animal studies, hydrogen appeared to reduce damage by acting as an antioxidant (a substance that prevents harmful chemical reactions), reducing inflammation, and protecting cells. However, the review notes that more human studies are needed before hydrogen can be used as a standard medical treatment.
Practical Takeaway
While early research suggests hydrogen may have protective properties against tissue damage from interrupted blood flow, this review is based on laboratory and animal studies, not human trials. Much more clinical research in humans is needed before hydrogen therapy can be recommended as a medical treatment for these conditions.
Abstract
Ischemia/reperfusion injury (IRI) represents a significant contributor to morbidity and mortality associated with various clinical conditions, including acute coronary syndrome, stroke, and organ transplantation. During ischemia, a profound hypoxic insult develops, resulting in cellular dysfunction and tissue damage. Paradoxically, reperfusion can exacerbate this injury through the generation of reactive oxygen species and the induction of inflammatory cascades. The extensive clinical sequelae of IRI necessitate the development of therapeutic strategies to mitigate its deleterious effects. This has become a cornerstone of ongoing research efforts in both basic and translational science. This review examines the use of molecular hydrogen for IRI in different organs and explores the underlying mechanisms of its action. Molecular hydrogen is a selective antioxidant with anti-inflammatory, cytoprotective, and signal-modulatory properties. It has been shown to be effective at mitigating IRI in different models, including heart failure, cerebral stroke, transplantation, and surgical interventions. Hydrogen reduces IRI via different mechanisms, like the suppression of oxidative stress and inflammation, the enhancement of ATP production, decreasing calcium overload, regulating cell death, etc. Further research is still needed to integrate the use of molecular hydrogen into clinical practice.